J. Esko
Molecular Biology · 1996–2020
A researcher in the Science corpus: 19 papers; trusts 2 researchers and is trusted by 9 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 54 citations into it; #5,522 of 17,773 by trust here, #5,227 by citations
- Cell Biology — 30 citations into it; #251 of 2,073 by trust here, #316 by citations
- Genetics — 11 citations into it; #4,698 of 6,854 by trust here, #5,761 by citations
- Organic Chemistry — 9 citations into it; #619 of 1,495 by trust here, #542 by citations
Whom J. Esko trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts J. Esko overall
- Xinhua Lin
- Ding Xu
- A. Varki
- K. Prydz
- Beverly M. Zak
- S. Sarrazin
- K. Ohtsubo
- B. Crawford
- William C. Lamanna
Papers from J. Esko's perspective
Ordered by how strongly the researchers J. Esko trusts endorse each paper. Same corpus, a different order for every researcher.
- Order out of chaos: assembly of ligand binding sites in heparan sulfate. (Annual Review of Biochemistry)
- Functions of cell surface heparan sulfate proteoglycans.
- Regulation of Cytokine Receptors by Golgi N-Glycan Processing and Endocytosis (Science)
- Structural basis for fibroblast growth factor receptor activation. (Cytokine & growth factor reviews)
- Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin (Nature)
- Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury. (Cell)
- The sweet and sour of cancer: glycans as novel therapeutic targets (Nature Reviews. Cancer)
- Developmental regulation of the growth plate (Nature)
- Role of glycosylation in development. (Annual Review of Biochemistry)
- The putative tumor suppressors EXT1 and EXT2 form a stable complex that accumulates in the Golgi apparatus and catalyzes the synthesis of heparan sulfate.
Their papers
- Symbol Nomenclature for Graphical Representations of Glycans. (2015) — 943 citations
- Molecular diversity of heparan sulfate. (2001) — 860 citations
- Order out of chaos: assembly of ligand binding sites in heparan sulfate. (2002) — 1,488 citations
- Heparan sulphate proteoglycans fine-tune mammalian physiology (2007) — 1,588 citations
- Proteoglycans and Sulfated Glycosaminoglycans (2009) — 637 citations
- The sweet and sour of cancer: glycans as novel therapeutic targets (2005) — 1,308 citations
- Demystifying Heparan Sulfate–Protein Interactions (2014) — 685 citations
- Heparan sulfate proteoglycans. (2011) — 1,427 citations
- SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2 (2020) — 797 citations
- SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2 (2020) — 342 citations
- Proteoglycans and Sulfated Glycosaminoglycans -- Essentials of Glycobiology (2009) — 61 citations
- Proteins that Bind Sulfated Glycosaminoglycans (2009) — 100 citations
- A Golgi-on-a-chip for glycan synthesis. (2009) — 19 citations
- Discovery and Classification of Glycan-Binding Proteins (2009) — 154 citations
- Cellular Organization of Glycosylation (2009) — 131 citations
- Glycosyltransferases and Glycan-processing Enzymes (2009) — 132 citations
- Hereditary multiple exostoses and heparan sulfate polymerization. (2002) — 204 citations
- Location of the glucuronosyltransferase domain in the heparan sulfate copolymerase EXT1 by analysis of Chinese hamster ovary cell mutants. (2000) — 93 citations
- Influence of core protein sequence on glycosaminoglycan assembly. (1996)